Lupin Limited, a global pharmaceutical company, has received tentative approval from the FDA
MaaT Pharma, a clinical-stage biotech firm, has recently disclosed the commencement of its phase
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, while Nephron
Glenmark Pharmaceuticals has achieved the ultimate endorsement from the United States Food and Drug Administration (USFDA)
Supriya Lifescience, one of India's leading specialty API manufacturing companies, signs an
Polarisar, a Miami-based startup dedicated to developing a new class of Mixed Reality surgical technology
Venus Remedies receives a three-star export house certificate from the Government of India.
Those at risk of developing type 2 diabetes already know how to avoid sugar, but new research
Union Minister for Science and Technology Jitendra Singh has expressed self assurance that India
The development of orphan drugs requires substantial research and innovation. This not only leads to the creation of new therapies for rare diseases but also advances scientific understanding and may have broader applications in medicine.
, CDSCO.jpg)
.jpg)